中国中医药科技
中國中醫藥科技
중국중의약과기
CHINESE JOURNAL OF TRADITIONAL MEDICAL SCIENCE AND TECHNOLOGY
2014年
5期
486-487,496
,共3页
晚期胃癌%扶正固本%T淋巴细胞亚群
晚期胃癌%扶正固本%T淋巴細胞亞群
만기위암%부정고본%T림파세포아군
advanced gastric cancer%Fuzheng guben%T lymphocyte subsets
目的:观察扶正固本法治疗对晚期胃癌患者的疗效和T淋巴细胞亚群的影响,探讨扶正固本治则治疗晚期胃癌的机理。方法:60例晚期胃癌患者,随机分为2组,治疗组与对照组各30例,对照组予以常规对症支持治疗,治疗组在常规对症支持治疗基础上,加服扶正固本方汤剂。观察治疗前后症状体征的变化及T细胞亚群的变化。结果:治疗组纳差、乏力等症状积分差值与对照组比较有显著差异(P<0.05);上腹痛、消瘦等症状治疗前后的积分差值,两组对比无差异(P>0.05);两组治疗前CD4+、CD8+及CD4+/CD8+均无显著差异( P>0.05);治疗后治疗组的CD8+与对照组比较无显著差异, CD4+及CD4+/CD8+较对照组有显著差异(P<0.05)。结论:扶正固本方有提高晚期胃癌患者机体免疫功能的作用。
目的:觀察扶正固本法治療對晚期胃癌患者的療效和T淋巴細胞亞群的影響,探討扶正固本治則治療晚期胃癌的機理。方法:60例晚期胃癌患者,隨機分為2組,治療組與對照組各30例,對照組予以常規對癥支持治療,治療組在常規對癥支持治療基礎上,加服扶正固本方湯劑。觀察治療前後癥狀體徵的變化及T細胞亞群的變化。結果:治療組納差、乏力等癥狀積分差值與對照組比較有顯著差異(P<0.05);上腹痛、消瘦等癥狀治療前後的積分差值,兩組對比無差異(P>0.05);兩組治療前CD4+、CD8+及CD4+/CD8+均無顯著差異( P>0.05);治療後治療組的CD8+與對照組比較無顯著差異, CD4+及CD4+/CD8+較對照組有顯著差異(P<0.05)。結論:扶正固本方有提高晚期胃癌患者機體免疫功能的作用。
목적:관찰부정고본법치료대만기위암환자적료효화T림파세포아군적영향,탐토부정고본치칙치료만기위암적궤리。방법:60례만기위암환자,수궤분위2조,치료조여대조조각30례,대조조여이상규대증지지치료,치료조재상규대증지지치료기출상,가복부정고본방탕제。관찰치료전후증상체정적변화급T세포아군적변화。결과:치료조납차、핍력등증상적분차치여대조조비교유현저차이(P<0.05);상복통、소수등증상치료전후적적분차치,량조대비무차이(P>0.05);량조치료전CD4+、CD8+급CD4+/CD8+균무현저차이( P>0.05);치료후치료조적CD8+여대조조비교무현저차이, CD4+급CD4+/CD8+교대조조유현저차이(P<0.05)。결론:부정고본방유제고만기위암환자궤체면역공능적작용。
Objective:Through the use of Fuzheng guben method in the treatment of advanced gastric cancer patients, to observe the curative effect and influence on T lymphocyte subsets , explore the mechanism of "Fuzheng Guben"therapy in the treatment of advanced gastric cancer .Methods: 60 cases of advanced gastric cancer patients were randomly divided into 2 groups:treatment group and the control group with 30 cases in each group, the control group was given routine symptomatic and supportive treatment , the treatment group was given Fuzheng guben decoction based on conventional symptomatic and supportive treatment , the changes of symptoms signs and T lymphocyte subsets wese observed .Results: In treatment group,anorexia, fatigue and other symp-toms integral was difference to compare with the control group ( P<0.05 );before and after treatment upper ab-dominal pain , weight loss and other symptoms integral was no difference between the two groups ( P>0.05 ) . There were no difference between the two groups on CD 4+,CD8 +and CD4+/CD8+changes before treated ,there were significant difference on CD4+and CD4+/CD8+(P<0.05)after treated,CD8 +change was no obvious.Con-clusion:Fuzheng guben decoction can inhance the immunologic function of advanced gastric carcer patients .